Riskpilot← Back to searchSign inGet full accessOPTIKER INGEBRIGTSEN LTD NUF
NUFActiveOrg 994818783Rollaugs Gate 4, 7800 NamsosRetail sale of medical and orthopaedic goods · NACE 4774Est. 20093 employees
Revenue 2024
NOK 2,6M
-10% vs 2023
EBITDA margin
-5.1%
-145% vs 2023
Equity ratio
59.3%
Financial strength
Net profit 2024
NOK -154K
-157% vs 2023
| Revenue | NOK 2,6M | -10% |
| EBITDA | NOK -134K | -145% |
| Net profit | NOK -154K | -157% |
| Total assets | NOK 485K | -18% |
| Equity | NOK 288K | -35% |
| Employees | 3 | — |
Legal name
OPTIKER INGEBRIGTSEN LTD NUF
Org number
994818783
Legal form
Norskregistrert Utenlandsk Foretak
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
28. november 2009
Share capital
—
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Rekvirering av synshjelpemidler som briller og kontaktlinser. Klinikk for synshelseundersøkelse. Eget laboratorium for produksjon av synshjelpemidler. Import av brilleinnfatninger, brilleglass, kontaktlinser, produksjonsapparater og tilhørende utstyr.
Address
Rollaugs Gate 4, 7800 Namsos
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 789 | 2 932 | 2 717 | 2 916 | 2 632 |
| Staff expenses | −814 | −1 179 | −1 082 | −722 | −798 |
| EBITDA | 116 | −361 | −38 | 299 | −134 |
| Depreciation & amort. | −21 | −33 | −24 | −26 | −19 |
| EBIT | 95 | −394 | −62 | 273 | −153 |
| Net financials | −5 | −1 | −2 | −4 | −1 |
| Profit before tax | 90 | −395 | −64 | 269 | −154 |
| Tax | 7 | −0 | −0 | −0 | −0 |
| Net profit | 83 | −395 | −64 | 269 | −154 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 912 | 500 | 458 | 592 | 485 |
| Equity | 631 | 236 | 172 | 441 | 288 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 280 | 264 | 286 | 151 | 197 |
| Total debt | 280 | 264 | 286 | 151 | 197 |
EBITDA margin
-5.1%
This company
15.8%
Market median
-132% vs market
20202024
Equity ratio
59.3%
This company
38.2%
Market median
+55% vs market
20202024
Return on equity
-53.4%
This company
18.4%
Market median
-390% vs market
20202024
Net profit margin
-5.8%
This company
8.1%
Market median
-172% vs market
20202024
Asset turnover
5.43×
This company
1.12×
Market median
+385% vs market
20202024
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HD Chief Executive Officer | Chief Executive Officer | 2026 |
FI Chief Executive Officer | Chief Executive Officer | 2009 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OPTIKER INGEBRIGTSEN LTD NUF also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Huy Dinh Tran | Chief Executive Officer | 0 companies |
| Frode Ingebrigtsen | Chief Executive Officer | 0 companies |